Literature DB >> 11850274

Mutator bacteria as a risk factor in treatment of infectious diseases.

Antoine Giraud1, Ivan Matic, Miroslav Radman, Michel Fons, François Taddei.   

Abstract

We show in a gnotobiotic mouse model that, in addition to direct selection of antibiotic-resistant bacteria, some antibiotic treatments also select for mutator alleles. Because of these mutator alleles' high mutation rates, the initial treatment failure increases the probability of failures in subsequent treatments with other drugs.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11850274      PMCID： PMC127494          DOI： 10.1128/AAC.46.3.863-865.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

1.  Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut.

Authors:  A Giraud; I Matic; O Tenaillon; A Clara; M Radman; M Fons; F Taddei
Journal:  Science       Date:  2001-03-30       Impact factor: 47.728

Review 2.  Mutation frequencies and antibiotic resistance.

Authors:  J L Martinez; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

3.  Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance.

Authors:  J Björkman; I Nagaev; O G Berg; D Hughes; D I Andersson
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

4.  Predicting the emergence of antibiotic resistance by directed evolution and structural analysis.

Authors:  M C Orencia; J S Yoon; J E Ness; W P Stemmer; R C Stevens
Journal:  Nat Struct Biol       Date:  2001-03

5.  High frequency of mutator strains among human uropathogenic Escherichia coli isolates.

Authors:  Erick Denamur; Stéphane Bonacorsi; Antoine Giraud; Patrick Duriez; Farida Hilali; Christine Amorin; Edouard Bingen; Antoine Andremont; Bertrand Picard; François Taddei; Ivan Matic
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

6.  Proliferation of mutators in A cell population.

Authors:  E F Mao; L Lane; J Lee; J H Miller
Journal:  J Bacteriol       Date:  1997-01       Impact factor: 3.490

7.  High mutation frequencies among Escherichia coli and Salmonella pathogens.

Authors:  J E LeClerc; B Li; W L Payne; T A Cebula
Journal:  Science       Date:  1996-11-15       Impact factor: 47.728

8.  Dominant negative mutator mutations in the mutS gene of Escherichia coli.

Authors:  T H Wu; M G Marinus
Journal:  J Bacteriol       Date:  1994-09       Impact factor: 3.490

9.  Mutator natural Escherichia coli isolates have an unusual virulence phenotype.

Authors:  B Picard; P Duriez; S Gouriou; I Matic; E Denamur; F Taddei
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

10.  A conspicuous adaptability to antibiotics in the Escherichia coli mutator strain, dnaQ49.

Authors:  K Tanabe; T Kondo; Y Onodera; M Furusawa
Journal:  FEMS Microbiol Lett       Date:  1999-07-01       Impact factor: 2.742
View more
  31 in total

Review 1.  Noise-driven heterogeneity in the rate of genetic-variant generation as a basis for evolvability.

Authors:  Jean-Pascal Capp
Journal:  Genetics       Date:  2010-06       Impact factor: 4.562

2.  Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus.

Authors:  Hiep N'Guyen Trong; Anne-Laure Prunier; Roland Leclercq
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

3.  Resistance to antimicrobial peptides and stress response in Mycoplasma pulmonis.

Authors:  Lina Fassi Fehri; Pascal Sirand-Pugnet; Géraldine Gourgues; Gwenaël Jan; Henri Wróblewski; Alain Blanchard
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  Induction and inhibition of ciprofloxacin resistance-conferring mutations in hypermutator bacteria.

Authors:  Ryan T Cirz; Floyd E Romesberg
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

5.  Intermediate mutation frequencies favor evolution of multidrug resistance in Escherichia coli.

Authors:  Erick Denamur; Olivier Tenaillon; Catherine Deschamps; David Skurnik; Esthel Ronco; Jean Louis Gaillard; Bertrand Picard; Catherine Branger; Ivan Matic
Journal:  Genetics       Date:  2005-06-18       Impact factor: 4.562

6.  Weak mutators can drive the evolution of fluoroquinolone resistance in Escherichia coli.

Authors:  Hanna Orlén; Diarmaid Hughes
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

7.  Mutation rate variability as a driving force in adaptive evolution.

Authors:  Dalit Engelhardt; Eugene I Shakhnovich
Journal:  Phys Rev E       Date:  2019-02       Impact factor: 2.529

8.  Fluoroquinolone resistance in Haemophilus influenzae is associated with hypermutability.

Authors:  María Pérez-Vázquez; Federico Román; Silvia García-Cobos; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2007-02-05       Impact factor: 5.191

9.  Experimental adaptation of Salmonella typhimurium to mice.

Authors:  Annika I Nilsson; Elisabeth Kugelberg; Otto G Berg; Dan I Andersson
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

10.  Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients.

Authors:  Olivia Gutiérrez; Carlos Juan; José L Pérez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.